Evolent Health (EVH) Accounts Payables (2015 - 2026)

Evolent Health has reported Accounts Payables for 12 years, with the latest figure at $38.8 million in Q2 2026.

• On a quarterly basis, Accounts Payables fell 44.11% year-over-year to $38.8 million in Q2 2026; TTM through Jun 2026 was $38.8 million, a 44.11% decrease from a year earlier, with the FY2025 full-year figure at $59.8 million, down 37.75% from the prior year.
• Accounts Payables was $38.8 million for Q2 2026 at Evolent Health, down from $63.0 million in the prior quarter.
• The five-year high for Accounts Payables was $96.6 million in Q2 2022, with the low at $38.8 million in Q2 2026.
• Average Accounts Payables over 5 years is $62.8 million, with a median of $60.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables soared 142.14% in 2022, then slumped 49.28% in 2024.
• Over 5 years, Accounts Payables stood at $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 99.03% to $96.0 million in 2024, then plunged by 37.75% to $59.8 million in 2025, then tumbled by 35.05% to $38.8 million in 2026.
• The last three Accounts Payables figures came in at $38.8 million (Q2 2026), $63.0 million (Q1 2026), and $59.8 million (Q4 2025), per Business Quant data.